• Aslam Pervaiz Inspectorate of Prisons Punjab
  • Fateh Sher Sipra Deputy District Office Health, Shalamar Town
  • Tanveer Hussain Rana Government Mian Munshi District Headquarter Hospital-1
  • Imran Qadeer Consultant Molecular Genetics, Sundus Foundation, Lahore


Background: Prisoners as a high risk group are never recommended for blood donations. In Pakistan, prisoners are legally allowed to donate blood and get thirty days extra remission. Inspectorate of prisons allowed Alizaib Foundation for blood donation camps subject to pre-donation screening of volunteer prisoner blood donor against infectious diseases. This study was conducted to identify the potential benefits of pre-donation screening. Methods: This cross sectional study was conducted in October, 2009 in Punjab. Intending volunteer prisoner blood donors from January, 2007 to September, 2009 from prisons of Punjab were included. Physically fit were tested for Hepatitis C Virus (HCV) and B Virus (HBV) by Rapid test kit before bleeding. Data was analysed by Epi-Info. Results: A total of 5894 male volunteer prisoner donors were screened and 1038 (17.6%) were rejected. The mean age was 28 years (range: 17–70 years). Of 5894, 857 (14.5%) were HCV positive and 222 (3.8%) were HBV positive. HCV & HBV co-infection was present among 41 (0.7%). Being convicted prisoner blood donor is significantly associated with higher seroprevalence for HCV (OR 1.35, 95% C.I. 1.17-1.57) and being under trial prisoner is significantly associated with higher seroprevalence for HBV (OR 1.40, 95% C.I. 1.06-1.85). Conclusion: Hepatitis B & C viruses were responsible for almost 18% prisoner blood donor rejection. Pre-donation screening of blood donors is an effective intervention to improve the safety and limit the cost of blood. Treatment of identified cases may contribute to public health. In the international scenario this study findings necessitate the amendments in the relevant prison rules.


Ministry of Health, Jamaica. National Transfusion Service 1999. Ministry of Health, Kingston Jamaica.

Ministry of Health, Jamaica. Surveillance report 1999, 2000 and 2001. Ministry of Health, Kingston, Jamaica.

Brady-West DC, Buchner LM. Retrospective audit of blood donation at a hospital-based blood centre, Implications for blood product supply and safety. West Indian Med J 2000;49(3):226–8.

Ampofo W, Nii-Trebi N, Ansah J, Abe K, Naito H, Aidoo S, et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiolol 2002;40(9):3523–5.

Cindy MW, Keith MS, Scott SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005;19(suppl 3):S41–6.

Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 2010;16 Suppl:S15–23.

Mumtaz S, Rehman MU, Muzaffar M, Hassan MU, Iqbal W. Frequency of seropositive blood donors for hepatitis B, C and HIV viruses in railway hospital. Rawalpindi. Pak J Med Res 2002;41(2):51–3.

Ryas M, Hussain T, Bhatti FA, Ahmed F, Tariq WZ, Khattak MF. Epidemiology of Hepatitis C Virus Infection in Blood Donors in Northern Pakistan. J Rawal Med Coll 2001;5(2):56–9.

Asif N, Khokhar N, Ilahi F. Sero-prevalence of HBV, HCV and HIV infection among voluntary non remunerated and replacement donors Northern Pakistan. Pak J Med Sci 2004;20(1):24–8.

Ahmed F, Shah SH, Tariq M, Khan JA. Prevalence of hepatitis B carrier and HIV in healthy blood donors at Ayub Teaching Hospital. Pak J Med Res 2000;39(2):91–2.

Mujeeb A, Aamir K, Mehmood K. Sero-prevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc 2000;50(8):269–70.

Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 2002;52(9):398–402.

Ali N, Khattak J, Anwar M, Tariq WZ, Nadeem M, Irfan M, et al. Prevalence of hepatitis B surface antigen and hepatitis C antibodies in young healthy adults. Pak J Pathol 2002;13(2):3–6.

Rahman MU, Akhtar GN, Lodhi Y. Transfusion transmitted HIV and HBV infections in Punjab, Pakistan. Pak J Med Sci 2002;18:18–25.

Ahmed M. Hepatitis B surface Antigen study in Professional and Volunteer Blood Donors. Ann Abbasi Shaheed Hosp Karachi Med Dent Coll 2001;6:304–6.

Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis c and hepatitis b virus infections in population. J Coll Physicians Surg Pak 2004;14(9):208–10.

Ali N, Nadeem M, Qamar A, Qureshi AH, Ejaz A. Frequency of Hepatitis C virus antibodies in blood donors in Combined Military Hospital, Quetta. Pak J Med Sci 2003;19(1):41–4.

Ahmad S, Gull J, Bano KA, Aftab M, Khokhar MS. Prevalence of Anti Hepatitis C antibodies in healthy blood donors at Services Hospital Lahore. Pak Postgrad Med J 2002;13(1):18–20.

Lone DS, Aman S, Aslam M. Prevalence of Hepatitis C Virus antibody in Blood Donors of Lahore. Biomedica 1999;15:103–7.

Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Quaye IK, Hesse IF, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol 2006;55( Pt 5):593–7.

Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 2000;33(1):27–30.

Haber PS, Parsons SJ, Harper SE, White PA, Rawlinson WD, Lloyd AR. Transmission of hepatitis C within Australian prisons. Med J Aust 1999;171(1):31–3.

Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005;19 Suppl 3:S41–6.

Stern V. A sin against the future: imprisonment in the world. London: Penguin; 1998.

Gough E, Kempf MC, Graham L, Manzanero M, Hook EW, Bartolucci A, et al. HIV and Hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. BMC Public Health 2010;10:777.

Centers for Disease Control and Prevention: HIV prevalence estimates -United States, 2006. JAMA 2009; 301(1):27–9.

Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002;35(3):305–12.

Maruschak L. HIV in Prisons, 2006. US Department of Justice, Bureau of Justice Statistics; Report No: NCJ-222179. Washington, DC, 2008. [Internet] [Cited 2010 May 12] Available from:

Hennessey KA, Kim AA, Griffin V, Collins NT, Weinbaum CM, Sabin K. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States. J Urban Health 2009;86(1):93–105.

Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52(RR-1):1–36.

Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. Am J Public Health 2002;92(11):1789–94.

Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009;13(1):9–19.

Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis 2008;8:43.

Rehman MU, Akhtar GN, Ladhi Y. Seroprevalence of Hepatitis-C antibodies in blood donors. Pak J Med Sci 2002;18(3);193–6.

Shah SM, Khattak IU, Ali A, Tariq M. Seropositivity for hepatitis B and C in voluntary blood donors. J Ayub Med Coll Abbottabad. 2010;22(3):149–51.

Khan ZT, Asim S, Tariq Z, Ehsan MA, Malik RA, Ashfaq B, et al. Prevelance of transfussion transmitted infections among healthy blood donors in Rawalpindi District, Pakistan: a five year survey. Int J Pathol 2007;5(1):21–5.

Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis 2007;11(5):407—12.

Khan NU, Siddique L, Ali I, Iqbal A, Munir I, Rashid F, et al. Prevalence of hepatitis B in the blood donors of N-W.F.P and FATA regions and the current scenario of HBV infection in Pakistan. Afr J Biotechnol 2010;9(37):6162–6.